---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-296870"
form_type: "8-K"
ticker: null
cik: "0001832415"
company_name: "Better Therapeutics, Inc."
filed_at: "2023-12-18T23:59:59+00:00"
generated_at: "2026-06-07T11:26:11.489248+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Better Therapeutics receives Nasdaq delisting notice; intends to appeal

## Summary
- Nasdaq notified Better Therapeutics on Dec 14, 2023 of delisting effective Dec 26, 2023 due to continued non-compliance with minimum bid price ($1.00) and MVLS ($35M) requirements.
- Company had 180-day compliance period ending Dec 13, 2023 but failed to regain compliance; not eligible for additional extension.
- Company intends to appeal to a Nasdaq Hearings Panel before Dec 21, 2023; appeal will stay delisting pending panel decision.
- No assurance that appeal will succeed or that listing on Nasdaq Capital Market will be maintained.

## SEC filing metadata
- accession: 0001193125-23-296870
- form_type: 8-K
- cik: 0001832415
- company_name: Better Therapeutics, Inc.
- filed_at: 2023-12-18T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832415/000119312523296870/0001193125-23-296870-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832415/000119312523296870/d48627d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-296870
- JSON: https://secwatch.observer/filing/0001193125-23-296870.json
- Plain text: https://secwatch.observer/filing/0001193125-23-296870.txt

## Key facts
- Listing & Compliance Notices
  Better Therapeutics, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5550(b)(2)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5550(b)(2)
  source text: continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires companies listed on the Nasdaq Capital Market to maintain a minimum bid price of at least $1 per share (the “Minimum Bid Price Requirement”). Nasdaq Listing Rule 5550(b)(2) requires companies listed on the Nasdaq Capital Market to maintain a minimum market value of listed
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832415/000119312523296870/0001193125-23-296870-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.